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Abstract 
Background: Health-related quality of life (HRQoL) is a valuable outcome measurement of 
treatment, particularly in patients undergoing therapy for malignancy. Due to the effects of 
both disease and treatment, it is important for clinicians to understand the holistic 
experience of the patient, not just the direct physical effect on morbidity and mortality. 
Oropharyngeal cancers are often treated with radiation to the head and neck, which 
presents a number of issues that will affect quality of life, including difficult to manage 
sequelae such as osteoradionecrosis. Dental extractions performed under any circumstances 
have an impact on quality of life, and those performed pre and post-radiotherapy are no 
exception. Aim: The aim of this study was to investigate the connection between pre-
radiotherapy dental extractions and self-reported health related quality of life. Methods: 
Retrospective data on patients treated with radiotherapy for oropharyngeal cancer were 
pooled with a cross-sectional survey. Results: greater than 8 pre-radiotherapy dental 
extractions, p16 negative status, female gender and positive smoking status were associated 
with statistically significant reduced quality of life. Conclusion: pre-radiotherapy dental 
extractions do not result in improved quality of life, and may in fact worsen it. 
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Introduction  
 
Radiotherapy (RT) is widely utilised for the management of head and neck cancer (HNC) and 
is associated with significant morbidity, manifest during treatment and often persisting 
permanently. One of the most feared late sequelae is osteoradionecrosis of the jaws (ORN), 
a condition of impaired wound healing characterised by non-vital bone in radiation fields not 
related to tumour recurrence[1]. Many risk factors for ORN exist including radiation dose, 
field and fractionation, tumour location, smoking and alcohol use, general health and 
nutrition status, oral health and oral hygiene. There also exist triggers that increase the 
likelihood of ORN developing, such as dental extractions, dental implants, surgery or poor 
fitting prostheses [2] as well as any residual foci of infection[3]. 
 
To minimise the risk of ORN and other radiation-related negative effects on the oral cavity, it 
is recommended that all patients are seen by a dental clinician prior to the commencement 
of treatment. At this visit, the oral status is assessed and appropriate dental treatments are 
completed. The dental needs of patients diagnosed with HNC are often quite high, and 
patients frequently present with periodontal disease and caries [4]. Initial screening and 
elimination of oral foci of infection has been shown to reduce post-radiotherapy 
complications such as osteoradionecrosis [5]. Dental extractions prior to radiotherapy have 
been advocated as a method of reducing such foci and therefore reducing 
osteoradionecrosis risk. In addition, they are advocated to reduce the need for post-
radiotherapy extractions which are more technically challenging and can lead to 
osteoradionecrosis. However, in some studies, the group that underwent pre-radiotherapy 
dental extractions had a higher rate of ORN[6]. 
 
An important factor when understanding treatment effects of neoplastic disease is the 
patient’s quality of life. A cancer diagnosis is often traumatic, and the treatment received 
has significant morbidity. In the case of head and neck cancer treated with RT, there can be 
significant effects on aesthetics, speech, eating and pain, as well as general effects on 
emotional state, social state and a general functional level [7]. There are numerous quality 
of life instruments available for the clinician or researcher to use, with a recent review 
finding 57 separate head and neck specific instruments published [8]. Quality of life 
instruments attempt to measure the human experience in order to produce a meaningful, 
thorough and comparable quantity that can be used to ascertain treatment effectiveness 
beyond the purely biological. This is obviously not an easy task.  
 
It has been reflected in the literature that fewer teeth are associated with reduced quality of 
life [9], however there are no studies published to date on the impact of RT related dental 
extractions on quality of life. As teeth are often extracted in the pre-RT period, it is 
hypothesised that dental extractions in this population result in a reduced oral health 
related quality of life. The competing theory is that pre-RT dental extractions provide a 
protective effect against outcomes that stand to impair quality of life, such as ORN, in such a 
significant way as to overpower the quality of life effect of tooth loss and provide a net 
benefit. In this study we aim to understand the effect that dental extractions had on quality 
of life for patients receiving RT for oropharyngeal cancer (OPC).  
  
 
Materials and Methods 
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Participant selection 
Patients over the age of 18 with OPC treated with curative intent definitive and/ or 
postoperative RT at two tertiary hospitals in an Australian state capital from 2005-2011 were 
invited to participate in the study. Patients underwent treatment planning through a 
multidisciplinary head and neck clinic and all received dental assessment, primary dental 
treatment and oral hygiene instruction before being discharged back to community dental 
clinics The dates chosen allowed sufficient post-treatment time to capture late 
complications, specifically ORN with a minimum time of 3 years. 190 participants completed 
the study, and 47 declined to participate. Data was collected between July and December 
2014. Ethics approval was obtained to complete the study.  
 
Data collection 
Consenting participants had their demographic and treatment data retrieved from hospital 
databases. Age, gender and smoking status were recorded. Diagnostic data included tumour 
location, tissue diagnosis, TNM staging and p16 status. Treatment data included radiation 
dose and site as well as the use and synchronicity of chemotherapy.  
Participants were given questionnaires requesting further information regarding their dental 
health and treatment in the preceding months before, during and following RT. Specifically, 
the location, timing and number of dental extractions were recorded. Subjective dental 
hygiene was recorded for pre- and post-treatment and participants were asked to disclose 
dental habits, denture use and service utilisation. The questionnaire gathered information 
regarding exposed bone after radiation treatment including duration, quadrant location and 
treatment with either surgical intervention and/or hyperbaric oxygen. Location site was 
confirmed with medical records and radiographs. 
Participants were given two self-reported quality of life instruments, the Oral Health Impact 
Profile 14 (OHIP-14)[10], and the Functional Assessment of Cancer Therapy – Head and Neck 
(FACT Head and Neck)[11] which they completed and returned. 
 
All data was de-identified, tabulated and stored in a secure database.  
The quality of life instruments were administered according to their guidelines.  
OHIP-14 scores were individually calculated based on additive measures.  
FACT Head and Neck scores were individually calculated according to the weighted method. 
Subset scores were recorded according to the Functional Assessment of Chronic Illness 
Therapy (FACIT) guidelines and recorded as physical well-being, social well-being, emotional 
well-being, functional well-being and head and neck specific. Derived scores were also 
calculated according to the guidelines and recorded as FACT-G, FACT-HN Total and Fact-HN 
Trial Outcome Index. FACT-G scores represent a general endpoint utilising the subsets of 
Physical, Social, Emotion and Functional Well Being are comparable with other FACIT family 
scores. FACT- Trial Outcome Index represents a physical and functional endpoint, which is 
calculated from Physical and Functional Well Being, and the Head and Neck specific score. 
The FACT total score encompasses all the subsets. 
Data underwent statistical analysis provided by an independent external statistician using 
Stata statistical software v12.0 (Statacorp, College Station, TX, USA).   
 
 
Results 
 
190 participants met the criteria and were included in the study, of which 132 (69.5%) were 
from hospital 1, and 58 (30.5%) were from hospital 2.  157 (82.6) were males and 33 (17.3%) 
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were females. The mean age was 64.9 (34.1-89.0, SD 8.3) with mean female age 61.2 and 
mean male age 65.7.  
 
Approximately half of the cases were tonsillar primary tumours (53.7%) followed by base of 
tongue (35.8%). Of known p16 status cases the great majority were positive (87.2%). 
Smoking status was divided into current smokers, ex-smokers and lifelong non-smokers, and 
respectively represented 16.9%, 54.9% and 28.2%, indicating over three-quarters were 
current or ex-smokers. The majority of histopathological diagnoses were SCC (95.3%) (Table 
1). Participants with a negative p16 status were more likely to be current smokers (26.7% 
compared with 12.7%) and ex smokers (60% compared with 52%).  
 
 
Treatment Modality 
All participants underwent RT as required by the study protocol. 167 (87.9%) underwent 
concurrent chemotherapy and RT. 21 (11.1%) underwent RT alone, and 2 (1.1%) underwent 
sequential chemotherapy and RT. The mean RT dose administered was 68 Gray (30-77, SD 
5.9). 
 
Pre-Radiotherapy Dental Extractions 
4 participants (2.1%) were edentulous prior to treatment. 129 (67.9%) of participants 
underwent dental extractions as part of their pre-RT treatment. 13 of this group underwent 
full clearances. Of the 129 cases who had pre-RT extractions, 20 (15.5%) went on to have 
post-RT extractions, leaving 109 having only pre-RT extractions. The mean number of teeth 
extracted for all cases was 5.1 (Range 0-24, SD 5.4). Teeth were extracted prior to RT at a 
total of 364 quadrant-extractions. More extractions were performed in the mandible at a 
ratio of 1:1.7. Quadrants 1 to 4 had 77, 72, 102 and 113 quadrant-extractions respectively. 
83.3% of current smokers, 54% of ex smokers and 70% of non-smokers underwent pre-
radiotherapy extractions. Of those who had more than 8 teeth extracted prior to 
radiotherapy, 19.5% were current smokers, 41.5% were ex-smokers and 39% were non-
smokers. Of those who had 1-7 extractions26.7%, 48.9% and 26.7% were current, ex and 
non-smokers respectively.  
 
Extractions during radiotherapy 
No participants had dental extractions during RT treatment. 
 
Post-Radiotherapy Dental Extractions 
30 participants underwent post-radiotherapy extractions, with 10 cases having them alone. 
The mean number of teeth extracted after RT for all cases was 0.85 (Range 0-20, SD 3.0). 
Teeth extracted post RT were balanced across the mouth, with extractions from quadrant 1 
to quadrant 4 as 16, 15, 15 and 16 respectively (Table 2). 
 
 
Osteoradionecrosis 
29 participants (15.3%) had developed ORN at the time of the study. ORN was 5.8 times 
more common in the mandible than the maxilla.  
 
25 of the 29 cases of ORN (86.2%) occurred in participants who underwent pre-RT 
extractions, and 22 of the 29 cases of ORN (75.9%) were in sites of pre-RT extraction. Of the 
25, 2 cases of ORN developed in participants who had full clearances, and 5 developed in 
participants who had both pre- and post-RT extractions. 
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4 cases of ORN (13.8%) developed in the site of post-RT extraction, and 3 (10.3%) were in 
the same quadrant that had undergone both pre- and post-RT extractions. 2 dentate 
participants developed ORN without undergoing pre- or post-RT extractions. No participants 
who were edentulous at the beginning of treatment developed ORN. 
 
Oral Hygiene Status 
Oral hygiene status was self reported, with an overall status, brushing times per day and 
dental visits per year recorded. Participants gave scores for their hygiene both prior to 
treatment and at the time of questionnaire, reported as poor, fair, good or excellent. Post-
treatment the results polarised and the excellent and poor groups made net gains (Table 3). 
 
 
Quality of Life Measures 
The range of values representing quality of life was broad, with the OHIP-14 scores ranging 
from the lowest possible score to 3 points below the highest possible score. A similar range 
was found for the FACT-Head and Neck subsets, with the results occupying a large 
proportion of the available options.  
 
It must be noted that the values for the OHIP-14 and the FACT-H&N measures have different 
meanings of their sign, ie a higher score for the OHIP-14 represents a poorer quality of life, 
whereas a higher score for the FACT-Head and Neck represents a richer quality of life. To 
derive the OHIP-14 mean as a percentage of the theoretical maximum, the inverse was used 
as to be more comparable (Table 4). 
 
 
OHIP-14  
Female gender was associated with a significantly worse quality of life (6.8 points). Other 
outcomes that negatively affected the quality of life according to the OHIP-14 score at the 
5% level were p16 status and smoking status. p16 negative cases had poorer quality of life, 
as did current and ex-smokers, with current smokers faring worse. 
 
Pre-RT dental extractions by number revealed that >8 were associated with a significantly 
worse quality of life than those who had no extractions. While 1-7 pre-RT extractions and 
post-RT extractions were associated with a reduced quality of life, this was not found to be 
significant at levels applied. When pre-RT dental extractions were taken as a binary yes or 
no, the effect on the quality of life was negative but not statistically significant. 
 
Other measures associated with a significantly reduced quality of life included pre-RT full 
clearance (14.05, p=0.046), and development of ORN (4.74, p=0.036). Current excellent 
dental hygiene was associated with a slightly improved quality of life (-1.92 points, p=0.004). 
 
There was not a great range of RT doses received to determine a significant effect on quality 
of life. When the doses are separated into the groups ‘less than 70 Gray’ and ‘greater than 
or equal to 70 Gray’ there is a negative but not significant effect on quality of life (3.38, 
p=0.54). Treatment received ie synchronised chemoradiotherapy and other intervention 
groups did not produce significant results, but again there was a great degree of 
homogeneity in the data (Table 5). 
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FACT Head and Neck Subset Scores 
The FACT- Head and Neck subset scores were analysed to further understand if associations 
could be made between particular domains of quality of life and interventions received. 
Here it can be seen that there is a significant association across all domains between 
reduced quality of life and smoking status as either current and or ex compared with lifelong 
non-smokers. p16 negative cases are associated with reduced quality of life in the Social and 
HNCS domains. Female gender was significantly associated with reduced quality of life in the 
Emotional Well Being domain (Table 6, Table 7). 
 
 
Discussion 
 
 
Comparison of Quality of Life Instruments 
Murphy et al reports that Quality of Life instruments can be categorised as either site-
specific (in this case, Head and Neck), symptom-specific or treatment-specific[12]. The 
selected instruments have been taken from different groups, namely the FACT- Head and 
Neck is a site-specific instrument, and the OHIP-14 is a symptom-specific instrument[8]. It 
was hypothesised that using instruments from differing paradigms would produce 
meaningful results. Additionally, data gained can introduce a comparison between the two 
instruments, as our literature review did not reveal any study comparing data from the 
OHIP-14 and the FACT- Head and Neck instruments. There was however, one study found 
which compared OHIP-14 to another member of the FACIT family, namely the FACT- Bone 
Marrow Transplant [13]. 
 
The studies have differing strengths and weaknesses. The OHIP-14 is derived from data 
collected from Australians and focuses on oral health symptoms [10]. This is important in 
order to capture any effect from oral hygiene as well as oral health interventions, such as 
dental extractions, as well as resulting in a high level of applicability as the current study 
population are Australian as well. The OHIP-14 is also short, and easy to use. However the 
OHIP-14 relates questions back to teeth, mouth or dentures, whereas the FACT-Head and 
Neck is more general, which may cause some answers to be different between the two. An 
example of this is the OHIP-14 question “Have you had painful aching in your mouth” and 
the FACT-Head and Neck statement “I have pain”. The FACT- Head and Neck instrument is 
utilised for breadth in that it captures general health data, and specificity in that the Head 
and Neck Specific questions have been determined especially for patients with head and 
neck cancer[11]. 
 
In this study, the mean of QoL outcomes is similar. The mean score expressed as a 
percentage of the theoretical maximum quality of life is 71.1% for OHIP-14 and 77% for 
FACT- Head and Neck. The OHIP-14 values ranged from the minimum theoretical (ie best 
possible quality of life) score of 0, to a maximum of 53 from the theoretical 56 (worst 
possible OHIP-14 score). Increased values for the two instruments have opposite meaning, 
and it can be seen that the FACT-Head and Neck ranges from a score of 147 of theoretical 
148 (best possible score) and to a score of 44 from 0 (worst possible score). So while the 
means are comparable, it can be seen that the OHIP-14 reports a wider range, and the FACT-
Head and Neck has a lesser range of negative quality of life scores. 
 
Demographics 
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The participants were derived from two major and similar hospitals of within the same city, 
69.5% from one and 30.5% from the other. The mean age was 64.9 (SD 8.3) and range 34.1 
to 89, which is higher than that of diagnosis in HPV-associated (53 years) and non-HPV 
associated (57 years)[14], but when follow up time of 3 to 9 years is included then this 
number approaches that in the literature. 
  
Extractions 
A large number of participants (67.9%) underwent extractions (mean 5.1 teeth) as part of 
their pre-RT work-up. This is in keeping with the literature showing head and neck cancer 
patients present with high dental needs and unmanaged risk factors, poor oral health 
literacy and low engagement with the dental profession, often persisting post-treatment [4, 
15, 16]. 15.5% (20) of those having pre-RT dental extractions went on to have post-RT dental 
extractions, with only 10 participants having post-RT extractions alone.  
 
Oral Hygiene 
Poor pre-RT dental hygiene habits have been published in the literature to persist following 
treatment [15], despite high adherence to oral hygiene methods leading to reduced 
complications [17, 18]. This must be seen as a joint responsibility of the patient and the head 
and neck oncology team, including the dental practitioner. In this study, we found that oral 
hygiene polarised following treatment, whereby the excellent and poor groups increased in 
number, and in fact the excellent group doubled from 20% to 39.7%. This was a subjective 
record, however it shows that despite morbid treatment there is chance of improving oral 
hygiene. All the participants in this study underwent dental consultation and oral hygiene 
information prior to RT, and it is hypothesised that such oral health education and 
intervention can have a positive impact on hygiene practises. 
 
Quality of Life Outcomes 
Much of the literature regarding quality of life for head and neck oncologic patients focuses 
on the difference between transoral robotic surgery and chemoradiotherary, or between 
HPV positive and negative tumours. Some comparable data does exist for this study in the 
form of OHIP-14 and FACT H&N results but due to the large number of different instruments 
used by various institutions, much opportunity for direct comparison is lost, and it is only 
possible to compare trends, with unclear inter-instrument reliability. 
 
The mean additive OHIP-14 score was 16.1, which is comparable to the score of 18.9 from a 
study of oral and oropharyngeal cancer survivors at least 6 months post-treatment, and 
contrasted to the mean of 5.9 from their control group[19]. Factors significantly reducing 
the quality of life per the OHIP-14 score were found to be female gender, p16 negative 
status, current vs never smoking status, current vs ex-smoking status, pre-RT dental 
extractions >8 and pre-RT full clearance. Development of ORN was associated with a worse 
quality of life. Excellent dental hygiene was found to improve quality of life. 
 
In regards to the FACT- Head and Neck scores, similar results were found. Smoking status 
resulted in worse quality of life outcomes in the domains of physical, social, emotional and 
functional well-being. P16 negative status worsened social well-being, head and neck 
specific scores and FACT-G (general) scores. Female gender worsened quality of life in the 
emotional well-being domain.  
 
Importantly, dental extractions both pre- and post-RT did not have a significant positive 
effect on quality of life post-treatment. While extractions did not have a significant 
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relationship (beyond >8 extractions and OHIP-14 score), both groups were associated with 
negative effects on quality of life. 
 
Smoking status has been found to be a predictor of not only post-treatment oral health 
related quality of life, but general health related quality of life in head and neck cancer 
survivors[20], and the current study confirms this relationship extends to a tiered system 
where current smokers, ex-smokers and non-smokers have improving quality of life. 
Additionally, our study confirms the previous findings that p16 positive cases have better 
quality of life over their counterparts [21], often attributed to improved survival, younger 
age and lack of smoking, although other studies have found no difference [22]. 
 
It is interesting but not surprising that excellent dental hygiene was associated with an 
improved quality of life score. Improved oral hygiene should lead to improved oral function, 
and then translate into measurable quality of life differences. 
 
Clinical Implications 
The clinical implications are broad. Firstly, the dental needs of head and neck cancer 
patients are high, and clinicians should make the management of this a priority, as oral 
hygiene can improve, and is associated with the development of post-treatment 
complications. Secondly, dental extractions prior to RT do not improve post-treatment 
quality of life, and may worsen it. Such extractions therefore require great consideration. 
Thirdly, there are modifiable risk factors that can improve quality of life, namely smoking 
status, as well as non-modifiable risk factors such as female gender and HPV status that 
clinicians should identify as requiring greater support from a quality of life perspective.  
 
Further Research 
The domains covered by quality of life instruments in the head and neck population have a 
large amount of consistency. However, with more than 57 instruments to choose from, 
there is a great need that the advocates for various quality of life instruments in produce or 
choose a standard instrument, available freely and in multiple languages, so that the 
international community may benefit from improved communication of collected data and 
enable higher powered statistical comparison. A higher powered and prospective study 
investigating dental extractions and quality of life would add great weight to this discussion. 
 
Limitations 
It is prudent to address the limitations of a study before discussing the merits of the results 
so as to ensure the outcomes are viewed in the correct light, and, more importantly, that 
future studies may be planned accordingly to account for such limitations and produce 
higher quality data. 
 
In this study, there are number of limitations. There is no true control, nor is there a pre-
treatment quality of life baseline, and there is evidence to suggest that longer term quality 
of life relates to baseline[12, 23]. Due to the nature of the study design, there are 
opportunities for bias to occur with participants selecting into and out of the study due to 
personal reasons, for example, developing ORN and desiring to express their concerns. 
Additionally there is survivorship bias, as all participants have been able to complete the 
requirements of the study, which selects for p16 positive malignancies and the inherent 
prognostic factors [24, 25]. 
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Conclusion 
 
Pre-radiotherapy dental extractions may impact health-related quality of life.  
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Table 1: Participant Demographics  
Tumour Site Cases T Stage Cases Prog Stage Cases 
Tonsil 102 TX 2 Stage I 5 
Base of Tongue 68 T0 3 Stage II 8 
Soft Palate 3 T1 44 Stage III 31 
Oropharynx 
Other or 
Unspecified 
17 T2 66 Stage IVA 134 
P16 status Cases T3 43 Stage IVB 7 
Positive 102 T4a 27 Not 
recorded 
5 
Negative 15 T4b 1   
Unknown 73 T Not recorded 4   
Smoking status Count N Stage    
Current smoker 24 N0 22   
Ex-smoker 78 N1 32   
Non-smoker 40 N2a 19   
Unknown 48 N2b 74   
Morphology Count N2c 24   
Squamous cell 
carcinoma 
181 N3 6   
Other 9 N Not 
recorded 
4   
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 Table 2: Dental extractions 
Extractions Count 
Pre-RT extractions 129 
Pre-RT full clearance 13 
Pre-RT extractions only 109 
Edentulous prior to 
treatment 
4 
Post RT extractions 30 
Post RT extractions only 10 
Pre- and Post-RT 20 
Pre- and/or Post-RT 139 
No extractions (Dentate) 47 
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Table 3: Oral Hygiene Status 
Oral Hygiene Poor Fair Good Excellent 
Pre-RT 2.6% 19.6% 57.7% 20.1% 
Post-RT 5.8% 11.6% 42.9% 39.7% 
Net change +3.2% -7.9% -14.8% +19.6% 
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Table 4: Quality of life outcomes 
Instrument Mean Min 
(Actual) 
Max 
(Actual) 
St Dev 
OHIP 14 16.1 0 53 12.7 
PWB 23.5 3 28 4.7 
SWB 21.6 0 28 6.6 
EWB 20.0 5 24 4.3 
FWB 22.0 4 28 5.7 
HNCS 27.1 8 40 7.6 
FACT TOI 72.6 19 96 15.7 
FACT G 87.1 36 108 17.1 
FACT H&N 114.2 44 147 22.9 
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Table 5: Linear regression for OHIP-14 
OHIP-14 
Variable Coefficient P value 95% Confidence Interval 
Age -0.15 0.119 -0.33 0.04 
Gender (M) -6.84 0.005* -11.53 -2.14 
Morphology -3.33 0.44 -11.87 5.22 
p16 (+ve)  -8.21 0.025* -15.38 -1.03 
Smoking Ex vs C -6.14 0.039* -11.96 -0.31 
Smoking N vs C -6.24 0.058* -12.69 0.20 
Pre RT exo 1-7 
vs 0 
3.82 0.090 -0.59 8.23 
Pre RT exo >8 vs 
0 
4.82 0.033* 0.40 9.23 
Post-RT exo 3.56 0.16 -1.40 8.52 
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Table 6: Linear regression for FACT Head and Neck 
Physical Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age 0.031 0.38 -0.038 0.099 
Gender (M) 0.78 0.38 -0.98 2.55 
Morphology 1.31 0.41 -1.84 4.47 
p16 (+ve)  .66 0.64 -2.15 3.47 
Smoking Ex vs C 2.27 0.037* 0.14 4.40 
Smoking N vs C 2.78 0.021* 0.42 5.13 
Pre RT exo 1-7 
vs 0 
-0.52 0.53 -2.17 1.12 
Pre RT exo >8 vs 
0 
-0.07 0.93 -1.72 1.58 
Post-RT exo -0.27 0.77 -2.11 1.57 
Social Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age  -0.01 0.80 -0.11 0.09 
Gender (M) 0.65 0.51 -1.87 3.16 
Morphology 1.50 0.66 -2.98 5.98 
p16 (+ve)   3.80 0.047* 0.06 7.55 
Smoking Ex vs C  2.87 0.06 -0.12 5.86 
Smoking N vs C 5.23 0.002* 1.93 8.54 
Pre RT exo 1-7 
vs 0 
 -1.66 0.16 -4.00 0.67 
Pre RT exo >8 vs 
0 
 -0.71 0.55 -3.05 1.62 
Post RT exo -0.26 0.84 -2.87 2.35 
Emotional Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age  0.04 0.17 -0.19 0.10 
Gender (M) 2.06 0.01* 0.47 3.66 
Morphology 1.33 0.36 -1.55 4.22 
p16 (+ve)  1.07 0.40 -1.44 3.58 
Smoking Ex vs C  0.97 0.33 -1.01 2.95 
Smoking N vs C 2.53 0.02* 0.34 4.73 
Pre RT exo 1-7 
vs 0 
 -0.75 0.92 -1.59 1.43 
Pre RT exo >8 vs 
0 
0.21 0.79 -1.31 1.71 
Post RT exo 0.14 0.87 1.54 1.83 
Functional Well Being 
Variable Coefficient P value 95% Confidence Interval 
Age  0.03 0.54 -0.06 0.11 
Gender (M) 0.52 0.63 -1.63 2.70 
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Morphology  1.57 0.42 -2.27 5.41 
p16 (+ve)  3.15 0.064 -0.19 6.48 
Smoking Ex vs C  3.75 0.005* 1.13 6.36 
Smoking N vs C 5.13 0.001* 2.24 8.03 
Pre RT exo 1-7 
vs 0 
-1.09 0.29 -3.10 0.92 
Pre RT exo >8 vs 
0 
-0.22 0.83 -2.22 1.79 
Post RT exo -1.16 0.31 -3.40 1.07 
HNCS 
Variable Coefficient P value 95% Confidence Interval 
Age  0.03 0.65 -0.09 0.14 
Gender (M) 0.76 0.60 -2.11 3.63 
Morphology  1.43 0.58 -3.70 6.55 
p16 (+ve)  4.55 0.035* 0.33 8.77 
Smoking Ex vs C  4.17 0.017* 0.75 7.60 
Smoking N vs C 3.66 0.058 -0.13 7.44 
Pre RT exo 1-7 
vs 0 
 -2.26 0.096 -4.93 0.40 
Pre RT exo >8 vs 
0 
-1.150 0.28 -4.13 1.20 
Post RT exo -1.68 0.27 -4.66 1.30 
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Table 7: Factor Head and Neck Derived Scores 
FACT TOI  
Variable Coefficient P value 95% Confidence Interval 
Age  0.08 0.48 -0.15 0.31 
Gender (M) 2.07 0.49 -3.85 7.98 
Morphology  4.31 0.42 -6.23 14.86 
p16 (+ve)   8.36 0.069 0.66 17.38 
Smoking Ex vs 
C 
10.19 0.005* 3.11 17.26 
Smoking N vs C 11.57 0.004* 3.74 19.39 
Pre RT exo 1-7 
vs 0 
 -3.87 0.17 -9.37 1.62 
Pre RT exo >8 vs 
0 
-1.75 0.53 -7.24 3.75 
Post RT exo -3.12 0.32 -9.25 3.02 
FACT G 
Variable Coefficient P value 95% Confidence Interval 
Age  0.09 0.49 -0.16 0.33 
Gender (M) 4.01 0.22 -2.43 10.46 
Morphology 5.72 0.33 -5.79 17.23 
p16 (+ve)  8.68 0.09* -1.40 18.74 
Smoking Ex vs C 9.86 0.014* 2.06 17.66 
Smoking N vs C 15.68 <0.0001* 7.05 24.31 
Pre RT exo 1-7 
vs 0 
-3.35 0.27 -9.36 2.67 
Pre RT exo >8 vs 
0 
-0.80 0.80 -6.81 5.22 
Post RT exo -1.55 0.65 -8.27 5.17 
FACT TOTAL 
Variable Coefficient P value 95% Confidence Interval 
Age 0.11 0.51 -0.22 0.45 
Gender (M) 4.78 0.28 -3.87 13.42 
Morphology 7.15 0.36 -8.29 22.59 
p16 (+ve)  13.23 0.051 -0.09 26.54 
Smoking Ex vs C 14.03 0.009* 3.62 24.44 
Smoking N vs C 19.33 0.001* 7.82 30.85 
Pre RT exo 1-7 
vs 0 
 -5.61 0.17 -13.67 2.44 
Pre RT exo >8 vs 
0 
-2.26 0.58 -10.31 5.80 
Post RT exo -3.23 0.48 -12.23 5.77 
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